Nonalcoholic fatty liver disease and cardiovascular risk
VL Misra, M Khashab, N Chalasani - Current gastroenterology reports, 2009 - Springer
Nonalcoholic fatty liver disease (NAFLD) is a very common cause of chronic liver disease in
the United States. A large proportion of patients with NAFLD have coexisting metabolic …
the United States. A large proportion of patients with NAFLD have coexisting metabolic …
[HTML][HTML] Non-alcoholic fatty liver disease and cardiovascular risk
R Patil, GK Sood - World journal of gastrointestinal pathophysiology, 2017 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …
Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association
Nonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …
believed to affect> 25% of adults worldwide. Unless specific testing is done to identify …
Nonalcoholic fatty liver disease and cardiovascular diseases: the heart of the matter
S Chiriac, C Stanciu, I Girleanu… - Canadian Journal of …, 2021 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent cause of liver
disease worldwide, comprising a plethora of conditions, ranging from steatosis to end‐stage …
disease worldwide, comprising a plethora of conditions, ranging from steatosis to end‐stage …
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis
Background & Aims There have been many studies of the effects of non-alcoholic fatty liver
disease (NAFLD) and the risk of cardiovascular disease (CVD), but these have produced …
disease (NAFLD) and the risk of cardiovascular disease (CVD), but these have produced …
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
J Luo, L Xu, J Li, S Zhao - European journal of gastroenterology & …, 2015 - journals.lww.com
Nonalcoholic fatty liver disease (NAFLD) is the hepatic component of the metabolic
syndrome. The aim of this review is to summarize the available data linking NAFLD with …
syndrome. The aim of this review is to summarize the available data linking NAFLD with …
Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?
MH Ahmed, NEOS Husain… - Journal of family …, 2015 - journals.lww.com
Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver
condition in Western World and across the globe. NAFLD prevalence is estimated to be …
condition in Western World and across the globe. NAFLD prevalence is estimated to be …
Nonalcoholic fatty liver disease and cardiovascular disease risk
RK Schindhelm, M Diamant, RJ Heine - Current Diabetes Reports, 2007 - Springer
Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes. Evidence is now accumulating that NAFLD is associated with obesity …
and type 2 diabetes. Evidence is now accumulating that NAFLD is associated with obesity …
Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists?
MH Ahmed, S Barakat, AO Almobarak - Journal of obesity, 2012 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is prevalent in people with the metabolic syndrome
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …
and type 2 diabetes and is present in up to one‐third of the general population. Evidence is …
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent and includes a spectrum of
abnormalities ranging from steatosis to cirrhosis. In this review, we address recent evidence …
abnormalities ranging from steatosis to cirrhosis. In this review, we address recent evidence …